| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.73▲ | 1.73▲ | 1.74▲ | 2.17▼ | 2.78▼ |
| MA10 | 1.72▲ | 1.77▼ | 1.82▼ | 2.29▼ | 3.56▼ |
| MA20 | 1.72▲ | 1.98▼ | 2.10▼ | 2.74▼ | 4.18▼ |
| MA50 | 1.99▼ | 2.23▼ | 2.29▼ | 3.69▼ | 10.52▼ |
| MA100 | 2.19▼ | 2.44▼ | 2.60▼ | 4.30▼ | 289.79▼ |
| MA200 | 2.43▼ | 3.14▼ | 3.50▼ | 7.41▼ | 363.25▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.021▲ | -0.014▼ | -0.041▼ | -0.043▼ | 1.975▲ |
| RSI | 44.701▼ | 31.207▼ | 29.319▼ | 24.135▼ | 31.455▼ |
| STOCH | 84.636▲ | 50.892 | 35.563 | 23.398 | 13.523▼ |
| WILL %R | -8.000▲ | -48.031 | -72.951 | -77.439▼ | -90.965▼ |
| CCI | 67.308 | -40.918 | -60.273 | -208.763▼ | -174.159▼ |
|
Thursday, September 03, 2026 07:19 AM
The early RAINIER data showed a 79% CR/CRi rate in evaluable frontline TP53-mutated AML patients, comparing favorably with a published 41% composite remission benchmark for venetoclax plus azacitidine ...
|
|
Thursday, September 03, 2026 05:06 AM
Remission results nearly double published ven/aza outcomes in patients with historically limited treatment successSEATTLE, WA / ACCESS Newswire / September 3, 2026 / Inc. (Nasdaq:APVO), a ...
|
|
Monday, August 24, 2026 02:02 AM
APVO READ THE FULL APVO RESEARCH REPORT Business Update Aptevo Therapeutics, Inc. (NASDAQ: APVO) is currently focused on the continued clinical progress with mipletamig, a $1.5 million non-dilutive ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 04/09/26 | 1.74 | 1.7961 | 1.64 | 1.74 | 271,120 |
| 03/09/26 | 2.11 | 2.18 | 1.37 | 1.71 | 1,662,141 |
| 02/09/26 | 2.34 | 2.77 | 2.33 | 2.60 | 959,708 |
| 01/09/26 | 2.44 | 2.44 | 2.34 | 2.34 | 31,046 |
| 31/08/26 | 2.35 | 2.45 | 2.35 | 2.44 | 29,693 |
| 28/08/26 | 2.46 | 2.46 | 2.32 | 2.365 | 20,992 |
| 27/08/26 | 2.40 | 2.42 | 2.34 | 2.42 | 30,122 |
| 26/08/26 | 2.49 | 2.5499 | 2.41 | 2.41 | 27,242 |
| 25/08/26 | 2.37 | 2.50 | 2.3006 | 2.46 | 57,541 |
| 24/08/26 | 2.66 | 2.66 | 2.41 | 2.42 | 191,622 |
|
|
||||
|
|
||||
|
|